P32 Chromic Phosphate Suspension

Manufacturer: AnazaoHealth Corporation
Effective date: 2012-06-19
Label type: HUMAN PRESCRIPTION DRUG LABEL
Version: 1
Source: full-release
Hydrated at: 2026-05-31 20:16:07

Label at a glance#

ProductP32 Sodium Phosphate

Active ingredientPHOSPHORUS P-32

Label structure7 sections

Indications and uses

P32 chromic phosphate is indicated for intracavitary instillation for the treatment of peritoneal or pleural effusions caused by metastatic disease, and may be injected interstitially for the treatment of cancer. It is also used in hemophilia patients for intraarticular injections. Radioactive phosphorous works by local irradiation by beta emission.

Dosage and administration

Shake the vial well before injection. For intraperitoneal instillation, administer 10-20 mCi For intrapleural instillation, administer 6 to 12 mCi Doses for interstitial use should be based on estimated gram weight of tumor, about 0.1 to 0.5 mCi/gm.

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

AnazaoHealth’s compounded P32 Chromic Phosphate is supplied as a sterile, nonpyrogenic aqueous solution. It contains 30 % dextrose solution, 1 mg sodium acetate, 2 % benzyl alcohol added as a preservative. Sodium hydroxide or hydrochloric acid may be added for pH adjustment.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Mechanism of Action

Radioactive phosphorous works by local irradiation by beta emission.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

P32 sodium phosphate should not be used in the presence of ulcerative tumors.

WARNINGS

WARNINGS SECTION

Not for intravascular injection.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Shake the vial well before injection.

For intraperitoneal instillation, administer 10-20 mCi

For intrapleural instillation, administer 6 to 12 mCi

Doses for interstitial use should be based on estimated gram weight of tumor, about 0.1 to 0.5 mCi/gm.

DECAY CHART

SPL UNCLASSIFIED SECTION

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Figure 1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
9869efd7-d6dd-0665-5b67-53adbe6ef15e	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
51808-127-01	2019-11-27	C162847	48780-1	9855d018-e4d4-cd31-e053-dbdaa90ab51a	P32 Chromic Phosphate Suspension

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
51808-127-01	P32 Sodium Phosphate	3 mL in 1 VIAL	INJECTION, SUSPENSION	3		1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
51808-127	P32 SODIUM PHOSPHATE INJECTION, SUSPENSION [ANAZAOHEALTH CORPORATION]	1	Legacy NDC, 1 package rows	20121015_4996cd1e-4338-43d7-b7aa-418909ab8c16.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
PHOSPHORUS P-32	ACTIVE INGREDIENT	690284A407	1
PHOSPHORUS P-32	ACTIVE MOIETY	690284A407	1
BENZYL ALCOHOL	INACTIVE INGREDIENT	LKG8494WBH	1
DEXTROSE	INACTIVE INGREDIENT	IY9XDZ35W2	1
SODIUM ACETATE	INACTIVE INGREDIENT	4550K0SC9B	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 5 matching rows.

P32 Sodium Phosphate
PHOSPHORUS P-32
DEXTROSE
BENZYL ALCOHOL
SODIUM ACETATE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
51808-127	51808-127-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 4 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
PHOSPHORUS P-32	690284A407	ACTIB
DEXTROSE	IY9XDZ35W2	IACT
BENZYL ALCOHOL	LKG8494WBH	IACT
SODIUM ACETATE	4550K0SC9B	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 103 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SUPPOSITORY / VAGINAL	NA		Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	INJECTION, SUSPENSION / INTRAVITREAL	0.39 %w/v		Exact identifier — unii candidate 32 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	SOLUTION / INTRAOCULAR		195 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SOLUTION / INTRAVENOUS		400 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	LIQUID / SUBCUTANEOUS	0.2 %w/v		Exact identifier — unii candidate 32 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / PARENTERAL		250 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	CAPSULE, EXTENDED RELEASE / ORAL	1.23 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	INJECTION / SUBCUTANEOUS		19 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	TABLET / ORAL	183.66 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	INJECTION / INTRADERMAL	1.6 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	INJECTION, SOLUTION / INTRAVENOUS	51.7 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SUPPOSITORY / RECTAL	129 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	TABLET, CHEWABLE / ORAL		1286 mg	Exact identifier — unii candidate 21 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRAMUSCULAR		1000 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SOLUTION / TOPICAL	2 %w/w		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	TABLET, DELAYED RELEASE / ORAL	2.31 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SUSPENSION / SOFT TISSUE		40 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	144 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / SOFT TISSUE		23 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SHAMPOO / TOPICAL	1.25 %w/w		Exact identifier — unii candidate 50 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	SOLUTION / ORAL	2489 mg/5ml		Exact identifier — unii candidate 21 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SUSPENSION / AURICULAR (OTIC)	0.9 %w/v		Exact identifier — unii candidate 50 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii candidate 21 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SUSPENSION / INTRASYNOVIAL		18 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	TABLET / SUBLINGUAL	115.78 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	LOTION / TOPICAL		4000 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	INJECTION / INTRAMUSCULAR		19 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	SOLUTION / INTRAVENOUS	5.05 %w/v		Exact identifier — unii candidate 21 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	POWDER, FOR SOLUTION / ORAL	0.1 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SOLUTION / INTRAMUSCULAR		500 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SUSPENSION / ORAL		100 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, EMULSION / INTRAVENOUS		45 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SOLUTION / INTRA-ARTICULAR		23 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	GEL / RECTAL		124 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	INJECTION, POWDER, FOR SOLUTION / PARENTERAL	12.5 mg		Exact identifier — unii candidate 32 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SOLUTION / INTRAVENOUS		242 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	PASTILLE / ORAL	826 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	SOLUTION / ORAL		360 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	SOLUTION / AURICULAR (OTIC)	0.02 %w/v		Exact identifier — unii candidate 32 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRACAVITARY	0.01 ml		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	TABLET / ORAL	1.06 mg		Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	INJECTION, SOLUTION / INTRAVENOUS		328 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRA-ARTICULAR	1 %w/v		Exact identifier — unii candidate 50 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	SPRAY, METERED / NASAL	50 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	SYRUP / ORAL	620 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	POWDER / VAGINAL	430 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRA-ARTERIAL	0.9 %w/v		Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	CAPSULE / ORAL		450 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	CONCENTRATE / ORAL	400 mg		Exact identifier — unii candidate 21 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	LIQUID / INTRAVENOUS	1.04 %w/v		Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	SOLUTION/ DROPS / OPHTHALMIC	1.24 %w/v		Exact identifier — unii candidate 32 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	CREAM / TOPICAL		160 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION / INTRAVENOUS		1620 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	INJECTION / INTRACAVITARY	0.1 ml		Exact identifier — unii candidate 32 equally ranked IID candidates
BENZYL ALCOHOL	BENZYL ALCOHOL	LKG8494WBH	INJECTION, SUSPENSION / INTRALESIONAL		20 mg	Exact identifier — unii candidate 50 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	LIQUID / INTRAVENOUS	0.2 %w/v		Exact identifier — unii candidate 32 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	INJECTION / INTRAMUSCULAR	5 %w/v		Exact identifier — unii candidate 21 equally ranked IID candidates
DEXTROSE	DEXTROSE	IY9XDZ35W2	TABLET, DELAYED RELEASE / ORAL	NA		Exact identifier — unii candidate 21 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	SYRUP / ORAL		43 mg	Exact identifier — unii candidate 32 equally ranked IID candidates
SODIUM ACETATE	SODIUM ACETATE	4550K0SC9B	SUSPENSION/ DROPS / AURICULAR (OTIC)	0.03 %w/v		Exact identifier — unii candidate 32 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
5ed86373-1e27-42fc-a3b3-b198944f0dff			4996cd1e-4338-43d7-b7aa-418909ab8c16	2012-06-19	Warnings	Exact identifier spl id: 5ed86373-1e27-42fc-a3b3-b198944f0dff spl set id: 4996cd1e-4338-43d7-b7aa-418909ab8c16

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.